» Articles » PMID: 1704016

T Cell Immunity and Interferon-gamma Secretion During Experimental Allergic Encephalomyelitis in Lewis Rats

Overview
Journal J Neuroimmunol
Specialty Neurology
Date 1991 Feb 1
PMID 1704016
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

An immunospot assay that detects single secretory cells was used to enumerate interferon-gamma secreting cells (IFN-gamma-sc) in mononuclear cell suspensions from the central nervous system (CNS) and peripheral lymphoid organs after actively induced experimental allergic encephalomyelitis (EAE) in Lewis rats. In the CNS compartment there was a significant increase in the number of IFN-gamma-sc preceding the onset of the clinical signs of EAE. Both in rats with EAE and rats immunized with Freund's complete adjuvant (FCA) the number of IFN-gamma-sc increased in peripheral lymphoid organs, as compared to non-immunized controls. In view of the potent immunoregulatory effects of IFN-gamma, its intra-CNS secretion may play a crucial role for clinicopathological events in EAE. To study the numbers of primed T cells that in response to myelin antigens produced IFN-gamma, mononuclear cell suspensions from peripheral lymphoid organs were precultured to allow for antigen uptake, presentation and T cell triggering, followed by enumeration of IFN-gamma-sc. T cells responding to a peptide of myelin basic protein (MBP) that previously have been shown encephalitogenic in Lewis rats, appeared initially and were quantitatively dominant over the course of EAE. Later, T cell reactivities to multiple regions of MBP appeared, showing that the concept of immunodominance in EAE is non-absolute and time dependent. Splenocyte cultures from EAE rats exposed to the different antigens showed a reduced number of IFN-gamma-sc compared to cultures not exposed to antigen, suggesting an antigen-induced suppression of T cell effector molecules.

Citing Articles

TLTF in cerebrospinal fluid for detection and staging of T. b. gambiense infection.

Abdulla M, Bakhiet M, Lejon V, Andersson J, McKerrow J, Al-Obeed O PLoS One. 2013; 8(11):e79281.

PMID: 24260185 PMC: 3834137. DOI: 10.1371/journal.pone.0079281.


Differential levels of resistance to disease induction and development of relapsing experimental autoimmune encephalomyelitis in two H-2b-restricted mouse strains.

Li J, Zhao X, Skoff R, Shaw M, Tse H J Neuroimmunol. 2011; 234(1-2):109-14.

PMID: 21482438 PMC: 3092848. DOI: 10.1016/j.jneuroim.2011.03.008.


Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model.

Ciesielski M, Kazim A, Barth R, Fenstermaker R Cancer Immunol Immunother. 2004; 54(2):107-19.

PMID: 15340764 PMC: 11032903. DOI: 10.1007/s00262-004-0576-y.


The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: implications for multiple sclerosis treatment.

Bourrie B, Bribes E, Esclangon M, Garcia L, Marchand J, Thomas C Proc Natl Acad Sci U S A. 1999; 96(22):12855-9.

PMID: 10536012 PMC: 23131. DOI: 10.1073/pnas.96.22.12855.


Induction of the trypanosome lymphocyte-triggering factor (TLTF) and neutralizing antibodies to the TLTF in experimental african trypanosomiasis.

Hamadien M, Lycke N, Bakhiet M Immunology. 1999; 96(4):606-11.

PMID: 10233748 PMC: 2326788. DOI: 10.1046/j.1365-2567.1999.00730.x.